© 1992 Oxford University Press
article-commentary |
Alterations in protein kinase C isozymes 
and ß2 in activated Ha-ras containing papillomas in the absence of an increase in diacyiglycerol
1Department of Toxicology, North Carolina State University Raleigh, NC 27695–7633
2Sphinx Pharmaceuticals Corporation Durham, NC 27717, USA
4To whom correspondence should be addressed
The levels of protein kinase C (PKC) activity, PKC isozymes, as well as the level of endogenous diacylglycerols (DAG) were examined in early emergence mouse skin papillomas and compared to the levels in the epidermis. The papillomas were derived from a two-stage carcinogenesis protocol in which mice were initiated with 7,12-dimethylbenz[a]anthracene (DMBA) and promoted twice weekly for only 12 weeks with 12-O-tetradecanoylphorbol-13-acetate (TPA). As expected, >90% of these early emergence papillomas contained an activated Ha-ras gene with an A
T transversion in the 61st codon. There was a TPA-independent, irreversible decrease in total PKC activity (70%) in the early emergence papifiomas compared to that in the epidennis. Immunoblot analysis of epidermis and papillomas taken 4 weeks following the cessation of TPA treatment, a time when PKC catalytic activity has completely recovered to control level in epidermis but not in papillomas, revealed that the levels of PKC-
and PKC-ß2 were dramatically decreased in the cytosol of the papillomas, while the levels of these two isozymes in the particulate fraction were approximately equal to the epidermis. PKC-
-
and -
immunoreactive proteins were present in both epidermis and papillomas and only minor changes were observed in the papillomas. PKC- and PKC- displayed a particulate fraction localization in both the epidermis and papillomas, while PKC- was found in both subcellular fractions. We were unable to detect PKC-
in mouse epidermis or papillomas. Since the level of DAG has been shown to be elevated in some ras-transformed cells, we examined DAG levels in the papillomas, as an increased DAG level could explain the constitutive decreases in the levels of PKC. Measurements of cellular DAG indicated that there was no elevation in the total pool of DAG in the early emergence papillomas. These data demonstrate an irreversible decrease in and alteration of the subcellular distribution of PKC- and ß2 in DMBA-initiated /TPA-promoted papillomas. These changes are TPA-independent, and occur in the absence of an elevation in the total pool of endogenous DAG. These alterations of PKC isozymes may be important early events in multistage tumorigenesis.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Garg, A. G. Ramchandani, and G. B. Maru Curcumin decreases 12-O-tetradecanoylphorbol-13-acetate-induced protein kinase C translocation to modulate downstream targets in mouse skin Carcinogenesis, June 1, 2008; 29(6): 1249 - 1257. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Li, D. L. Wheeler, W. Alters, L. Chaiswing, A. K. Verma, and T. D. Oberley Early Epidermal Destruction with Subsequent Epidermal Hyperplasia Is a Unique Feature of the Papilloma-Independent Squamous Cell Carcinoma Phenotype in PKC{varepsilon} Overexpressing Transgenic Mice Toxicol Pathol, October 1, 2005; 33(6): 684 - 694. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hara, Y. Saito, T. Hirai, K. Nakamura, K. Nakao, M. Katsuki, and K. Chida Deficiency of Protein Kinase C{alpha} in Mice Results in Impairment of Epidermal Hyperplasia and Enhancement of Tumor Formation in Two-Stage Skin Carcinogenesis Cancer Res., August 15, 2005; 65(16): 7356 - 7362. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Reddig, N. E. Dreckschmidt, J. Zou, S. E. Bourguignon, T. D. Oberley, and A. K. Verma Transgenic Mice Overexpressing Protein Kinase C{{epsilon}} in Their Epidermis Exhibit Reduced Papilloma Burden but Enhanced Carcinoma Formation after Tumor Promotion Cancer Res., February 1, 2000; 60(3): 595 - 602. [Abstract] [Full Text]
|
|
|
|
|
|
P. J. Reddig, N. E. Dreckschimdt, H. Ahrens, R. Simsiman, C.-P. Tseng, J. Zou, T. D. Oberley, and A. K. Verma Transgenic Mice Overexpressing Protein Kinase C{{delta}} in the Epidermis Are Resistant to Skin Tumor Promotion by 12-O-Tetradecanoylphorbol-13-acetate Cancer Res., November 1, 1999; 59(22): 5710 - 5718. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Wang and R. Smart Overexpression of protein kinase C-alpha in the epidermis of transgenic mice results in striking alterations in phorbol ester-induced inflammation and COX-2, MIP-2 and TNF-alpha expression but not tumor promotion J. Cell Sci., January 10, 1999; 112(20): 3497 - 3506. [Abstract] [PDF]
|
|